Fairvalue-Calculator Fairvalue-Calculator
EN DE

Gencurix Inc (229000) Fair Value & Analysis

Healthcare · KR · Market cap 32.8B KRW

Price2,150 KRW
Fair Value1,828 KRW
Upside-15.0%
Quality95/100
Evidence: Low Range 1,371 KRW – 2,285 KRW

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Gencurix Inc (229000) currently trades at 2,150 KRW, while our model-based Fair Value estimate is 1,828 KRW — implying the stock looks roughly 15.0% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

About the company

Gencurix Inc. provides diagnostic solutions in South Korea. Its products include GenesWell BCT, a multigene diagnostic test for breast cancer; Droplex, a genetic test based on digital PCR platform; eDX, an early diagnosis for cancer with liquid biopsy; GenePro SARS-CoV-2 Test kit; GenoCTC, a circulating tumor cell isolator; and GenePro LAMP Cycler, a portable device for infectious disease detection. The company has a strategic alliance with Qiagen N.V. for the development of oncology assays for use on the QIAcuityDx platform. The company was founded in 2011 and is headquartered in Seoul, South Korea.

Open the full interactive analysis →

Similar stocks

Thermo Fisher Scientific Inc (TMO) -54% Danaher Corporation (DHR) -54% WuXi AppTec Co (WUXAY) +35% IDEXX Laboratories, Inc (IDXX) -53% Lonza Group (LZAGY) -74% Agilent Technologies, Inc (A) -52%

Frequently asked questions

Is Gencurix Inc (229000) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 1,828 KRW versus a price of 2,150 KRW — about −15% (overvalued). Model-based estimate, not financial advice.
What is the fair value of 229000?
Our 21-model fair value for Gencurix Inc is 1,828 KRW (as of Jun 24, 2026), built from audited fundamentals. The current price is 2,150 KRW.
What is the quality score of 229000?
Gencurix Inc has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.